Sleep as an outcome measure in ADHD randomized controlled trials: A scoping review

被引:13
|
作者
McWilliams, Scout [1 ]
Zhou, Ted [1 ]
Stockler, Sylvia [1 ,2 ]
Elbe, Dean [3 ,4 ]
Ipsiroglu, Osman S. [1 ,4 ,5 ,6 ]
机构
[1] Univ British Columbia, BC Childrens Hosp, Dept Pediat,Res Inst, H Behav Res Lab,Previously Sleep Wake Behav Res L, Vancouver, BC, Canada
[2] Univ British Columbia, BC Childrens Hosp, Dept Pediat, Div Biochem Genet, Vancouver, BC, Canada
[3] BC Childrens Hosp, Dept Pharm, Vancouver, BC, Canada
[4] Univ British Columbia, BC Childrens Hosp, Dept Pediat, Div Child & Adolescent Psychiat, Vancouver, BC, Canada
[5] Univ British Columbia, BC Childrens Hosp, Dept Pediat, Div Dev Pediat, Vancouver, BC, Canada
[6] Univ British Columbia, BC Childrens Hosp, Dept Pediat, Div Respirol, Vancouver, BC, Canada
关键词
Neurodevelopmental disorders; Mental health disorders; Insomnia; Medications; Stimulants; ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; GUANFACINE EXTENDED-RELEASE; DEFICIT-HYPERACTIVITY DISORDER; MIXED AMPHETAMINE SALTS; RESTLESS LEGS SYNDROME; SCHOOL-AGED CHILDREN; DOUBLE-BLIND TRIAL; STIMULANT MEDICATION; PARALLEL-GROUP; RATING-SCALE;
D O I
10.1016/j.smrv.2022.101613
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Sleep disturbances are highly prevalent among children with ADHD. Yet, diagnostic and treatment regimens are primarily focused on daytime symptomatology. The goals of this scoping review are to 1) identify interventional ADHD RCTs that have used sleep as an outcome measure, 2) describe and assess the validity of tools utilized to measure sleep-specific outcomes. 40/71 RCTs used sleep as a primary outcome. Actigraphy (n = 18) and sleep log/diary (n = 16) were the most common tools to measure sleep, followed by Children's Sleep Habits Questionnaire (n = 13), and polysomnography (n = 10). Sleep was a secondary outcome in 31 RCTs. Polysomnography and actigraphy used a heterogeneous spectrum of sleep-related variables and technical algorithms, respectively. 19/23 sleep questionnaires were validated covering a spectrum of sleep-related domains. Despite the intrinsic nature of sleep disturbances in ADHD, the number of RCTs measuring sleep-specific outcomes is limited and tools to measure outcomes are not standardized. Given the potential adverse effects of ADHD medications on sleep, sleep should be included as a core outcome measure in future clinical trials. Crown Copyright (C) 2022 Published by Elsevier Ltd. All rights reserved.
引用
收藏
页数:17
相关论文
共 50 条
  • [21] Results of Neurofeedback in Treatment of Children with ADHD: A Systematic Review of Randomized Controlled Trials
    Inmaculada Moreno-García
    Almudena Cano-Crespo
    Francisco Rivera
    Applied Psychophysiology and Biofeedback, 2022, 47 : 145 - 181
  • [22] A systematic review of randomized controlled trials of bupropion versus methylphenidate in the treatment of ADHD
    Maneeton, B.
    Maneeton, N.
    Intaprasert, S.
    Woottiluk, P.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2014, 24 : S202 - S203
  • [23] Results of Neurofeedback in Treatment of Children with ADHD: A Systematic Review of Randomized Controlled Trials
    Moreno-Garcia, Inmaculada
    Cano-Crespo, Almudena
    Rivera, Francisco
    APPLIED PSYCHOPHYSIOLOGY AND BIOFEEDBACK, 2022, 47 (03) : 145 - 181
  • [24] Addressing missing outcome data in randomised controlled trials: A methodological scoping review
    Medcalf, Ellie
    Turner, Robin M.
    Espinoza, David
    He, Vicky
    Bell, Katy J. L.
    CONTEMPORARY CLINICAL TRIALS, 2024, 143
  • [25] Randomized controlled trials in de-implementation research: a systematic scoping review
    Aleksi J. Raudasoja
    Petra Falkenbach
    Robin W. M. Vernooij
    Jussi M. J. Mustonen
    Arnav Agarwal
    Yoshitaka Aoki
    Marco H. Blanker
    Rufus Cartwright
    Herney A. Garcia-Perdomo
    Tuomas P. Kilpeläinen
    Olli Lainiala
    Tiina Lamberg
    Olli P. O. Nevalainen
    Eero Raittio
    Patrick O. Richard
    Philippe D. Violette
    Jorma Komulainen
    Raija Sipilä
    Kari A. O. Tikkinen
    Implementation Science, 17
  • [26] ORAL MEDICATION FOR AGITATION OF PSYCHIATRIC ORIGIN: A SCOPING REVIEW OF RANDOMIZED CONTROLLED TRIALS
    Mullinax, Samuel
    Shokraneh, Farhad
    Wilson, Michael P.
    Adams, Clive E.
    JOURNAL OF EMERGENCY MEDICINE, 2017, 53 (04): : 524 - 529
  • [27] Stroke rehabilitation evidence and comorbidity: a systematic scoping review of randomized controlled trials
    Nelson, Michelle L. A.
    McKellar, Kaileah A.
    Yi, Juliana
    Kelloway, Linda
    Munce, Sarah
    Cott, Cheryl
    Hall, Ruth
    Fortin, Martin
    Teasell, Robert
    Lyons, Renee
    TOPICS IN STROKE REHABILITATION, 2017, 24 (05) : 374 - 380
  • [28] Consent models in Canadian critical care randomized controlled trials: a scoping review
    O'Hearn, Katie
    Gibson, Jess
    Krewulak, Karla
    Porteous, Rebecca
    Saigle, Victoria
    Sampson, Margaret
    Tsampalieros, Anne
    Barrowman, Nick
    Cameron, Saoirse
    CANADIAN JOURNAL OF ANESTHESIA-JOURNAL CANADIEN D ANESTHESIE, 2022, 69 (04): : 513 - 526
  • [29] Measurement of specific organ domains in lupus randomized controlled trials: a scoping review
    Connelly, Kathryn
    Vettivel, Jeevan
    Golder, Vera
    Kandane-Rathnayake, Rangi
    Morand, Eric F.
    RHEUMATOLOGY, 2022, 61 (04) : 1341 - 1353
  • [30] Randomized controlled trials in de-implementation research: a systematic scoping review
    Raudasoja, Aleksi J.
    Falkenbach, Petra
    Vernooij, Robin W. M.
    Mustonen, Jussi M. J.
    Agarwal, Arnav
    Aoki, Yoshitaka
    Blanker, Marco H.
    Cartwright, Rufus
    Garcia-Perdomo, Herney A.
    Kilpelainen, Tuomas P.
    Lainiala, Olli
    Lamberg, Tiina
    Nevalainen, Olli P. O.
    Raittio, Eero
    Richard, Patrick O.
    Violette, Philippe D.
    Komulainen, Jorma
    Sipila, Raija
    Tikkinen, Kari A. O.
    IMPLEMENTATION SCIENCE, 2022, 17 (01)